Skip to main content
. 2017 Dec 22;9(6):7136–7147. doi: 10.18632/oncotarget.23606

Table 5. Results of the association between Taq I polymorphism and PCa risk in different genotyping method.

Comparison Studies Overall effect Heterogeneity Publication bias
OR Z-score p-value I2 P-value Begg's test Egger's test
PCR-RFLP
tt vs TT 29 0.88 [0.71–1.01] 1.13 0.258 46% 0.006 0.393 0.283
Tt vs TT 29 0.94 [0.80–1.10] 0.77 0.441 62% 0.000 0.970 0.702
tt/Tt vs TT 29 0.91 [0.79–1.05] 1.31 0.19 57% 0.000 0.851 0.995
tt vs TT/Tt 29 0.90 [0.71–1.13] 0.93 0.35 58% 0.000 0.307 0.277
t vs T 29 0.92 [0.82–1.03] 1.51 0.13 59% 0.000 0.476 0.424
TaqMan
tt vs TT 4 0.71 [0.53–0.94] 2.38 0.017 32% 0.219 1.000 0.794
Tt vs TT 4 0.85 [0.69–1.05] 1.50 0.134 44% 0.147 0.174 0.691
tt/Tt vs TT 4 0.82 [0.65–1.02] 1.79 0.074 53% 0.093 0.497 0.812
tt vs TT/Tt 4 0.77 [0.64–0.93] 2.68 0.007 3% 0.378 1.000 0.618
t vs T 4 0.83 [0.71–0.97] 2.36 0.018 49% 0.117 1.000 0.995
SNPlex
tt vs TT 3 0.95 [0.75–1.20] 0.43 0.669 0% 0.322 0.317 -
Tt vs TT 3 0.91 [0.60–1.39] 0.43 0.664 78% 0.010 0.602 0.999
tt/Tt vs TT 3 0.92 [0.64–1.33] 0.45 0.656 74% 0.022 0.602 0.997
tt vs TT/Tt 3 1.01 [0.81–1.25] 0.05 0.961 0% 0.783 0.317 -
t vs T 3 0.96 [0.82–1.23] 0.52 0.603 37% 0.203 0.602 0.987